Portfolio company
Intervacc
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Intervacc develops and supplies recombinant protein vaccines and medicines for horses and livestock to veterinarians and animal owners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
The Vaccine Group
The company develops recombinant viral-vector vaccines and biotherapeutics for livestock and companion animals to control infectious and chronic diseases.
ViroVet
This company develops vaccines and antiviral drugs for livestock to control respiratory diseases and other viral infections in cattle, swine, sheep and goats.
ArkVax
ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.
Animal Probiotics Sweden AB
This company develops and provides species-specific probiotic supplements for dogs, horses and cats to enhance their gastrointestinal health and general wellbeing.
Equinvest
This company provides veterinary care products and supplies through an online marketplace for horse owners and veterinary professionals.
Okapi Sciences
The company develops antiviral drugs for veterinary applications to treat viral infections in pets and livestock.
Aptimmune
This company develops and manufactures mucosal vaccines for the global commercial swine industry to prevent viral respiratory diseases in livestock.
Vimian
This company provides pharmaceuticals, medical technology, diagnostics and services to veterinary professionals and pet owners to improve animal health.